维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

10篇 您的检索式：作者名="Dito"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Phase Ⅱ study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcino ma of the pancreas显示文摘	Ko AH Dito E Schillinger B	2006	J Clin Oncol2006，24，3：	1
	2	A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer显示文摘	Andrew H. Ko Alan P. Venook Emily K. Bergsland R. Kate Kelley W. Michael Korn Elizabeth Dito Brian Schillinger Janet Scott Jimmy Hwang Margaret A. Tempero	2010	Cancer Chemotherapy and Pharmacology2010，，6：	1
	3	PhaseⅡstudy of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas显示文摘	Ko AH Dito E Schillinger B		0，，03：	1
	4	A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer:Is an anti-VEGF strategy still applicable?显示文摘	Ko AH Dito E Schillinger B	2008	Invest New Drugs2008，26，5：	1
	5	Phase II study of fixed dose rategemcitabine with cisplatin for metastatic adenocarcinoma of the pan-creas 显示文摘	Ko AH Dito E Schillinger B	2006	J Clin Oncol2006，24，3：	1
	6	Phase Ⅱ study of fixed dose rate gemeitabine with eisplatin for metastatic adeno- carcinoma of the pancreas 显示文摘	Ko AH Dito E Schillinger B	2006	J Clin Oncol2006，24，3：	1
	7	A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer显示文摘	Andrew H. Ko Alan P. Venook Emily K. Bergsland R. Kate Kelley W. Michael Korn Elizabeth Dito Brian Schillinger Janet Scott Jimmy Hwang Margaret A. Tempero	2010	Cancer Chemotherapy and Pharmacology2010，，6：	1
	8	A phase Ⅱ study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer:is an anti-VEGF strategy still applicable显示文摘	Ko AH Dito E Schillinger B	2008	Invest New Drugs2008，26，5：	1
	9	Phase II study of fixed dose rate gemcitabine with cisplatin for Metastatic adenocarcinoma of the pancreas 显示文摘	KO A H DITO E SCHILLINGER B	2006	J Clin Onco12006，24，3：	1
	10	Addition of surfactants to Low Salinity Waterflooding in microfluidics system to increase oil recovery显示文摘This study was conducted to investigate the phenomenon of oil removal from inside pores using a self-designed microfluidic test kit.An artificial micromodel chip as a representation of porous rocks has been created with a uniform pore structure design and made of PMMA(Polymethyl Methacrylate)material.The micromodel chip has a porosity of 27.8%as well as a permeability of 2.7 Darcy.By using the microfluidic test kit,this study has investigated how low salinity water(LSW)injection with MgCl_(2)divalent ions and the addition of anionic surfactant,linear alkylbenzene sulfonate mixed with nonionic surfactants,nonylphenol ethoxylate(NP-10)affects to oil recovery.The injection of LSW and surfactant solution was carried out with different injection stages,injection rates and surfactant solutions con-centrations.Visual images during the injection process are recorded for analysis,which is the advantage of dynamic testing using this microfluidic test kit over conventional coreflooding.From this study,it is indicated that the selection of ions contained in LSW affects the success of LSW injection.Reducing the surfactant injection rate from 50 mL/min to 20 mL/min can increase the oil recovery from 1.27%to 4.29%.Oil recovery was also higher on surfactant injection which resulted in lower interfacial tension of the system based on the calculation of interfacial tension obtained from the Chun-Huh and Ghosh equations from the Winsor test.From all injection scenarios carried out in this study,the highest increase in oil recovery of 26.87%OOIP was obtained by injecting surfactant solutions directly in the secondary stage without prior LSW injection.	Dito Fauzi Winanda Sanggono Adisasmito	2022	Petroleum Research2022，7，4：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费